by admin | Feb 20, 2024 | Uncategorized
Aston University has issued a press release highlighting the work of Evolution Therapeutics and our mission to leverage the pro-resolving properties of extracellular vesicles for the treatment of non-healing wounds, such as diabetic foot ulcers, which impose a...
by admin | Jan 30, 2024 | News&blogs, Uncategorized
Exciting news from Evolution Therapeutics as we welcome Alice Wigington, who has joined the team as a Research Scientist. Alice is a first-class graduate of Aston University’s integrated master’s programme in Biological Sciences, bringing strong expertise in...
by admin | Dec 8, 2023 | Uncategorized
Evolution Therapeutics has been recognised by the Biotechnology and Biosciences Research Council (BBSRC) in their 2023 impact showcase. This showcase serves as a compilation of impact stories stemming from BBSRC investments, shedding light on significant outcomes...
by admin | Nov 3, 2023 | Uncategorized
EVolution Therapeutics is thrilled to announce its selection to join the first cohort of SPARK The Midlands, the inaugural UK branch of the globally recognised Stanford preclinical accelerator model. Collaborating with esteemed partners like Aston University and the...
by admin | Sep 21, 2023 | News&blogs, Uncategorized
CEO of EVolution therapeutics, Dr James Gavin, was invited to present at the first-ever Midlands EV Network event. Here he shared his experience of co-founding EVolution Therapeutics, a company deeply rooted in the West Midlands and highlighted the tremendous...
by admin | Sep 18, 2023 | Uncategorized
EVolution Therapeutics has achieved another milestone by securing additional grant funding of £238,000, to work in collaboration with world leading biomaterials expert, Professor Paul Topham. This funding aims to bolster the development of polymer hydrogel delivery...